The Neurovascular Devices Market was valued at $2.08Million in 2018 and is forecast to grow at a modest5.5 % CAGR between2018 and 2025, culminating in 2026 global sales of $3.8Billion.
Neurovascular devices help in the treatment of several neurovascular disorders like intracranial atherosclerotic and cerebral aneurysm disease. The upsurge in the geriatric population and increase in a number of patients suffering from neurovascular disorders are anticipated to drive the market growth. Additionally, growth in acceptance of new minimally invasive techniques, for example, carotid artery stenting,and flow diversion lift the market growth. So, the high cost of the medical devices and lack of neurosurgeons are projected to boost the market growth. According to WHO there are 800,000 people are suffering from strokes which are the fourth leading mortality factor in the U.S. in between them 76% people are having 65 ages and over is anticipated to grow by 59% from 800 million people in 2018 to 1.8 billion by 2028. Governing policies about medical devices fluctuate in different countries. To confirm maximum availability and safe procedure of medical devices, the union of guidelines for these devices is important. In Minimally invasive surgery helps to the patients as well as less blood loss, decrease pain, and cost-effectiveness will upsurge acceptance of neurovascular surgeries and the market growth. Some Major companies concentrating on new product launches by implementing innovative technologies to acquire market profits with better disease treatment.
